Wyeth/Elan Submit Pharmacogenomics Study Report From Alzheimer’s Trial To FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
A gene expression study based on blood samples from a failed vaccine candidate trial could help develop other potential therapies, Wyeth says.